Theratechnologies Inc. Stock price
Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.
Key metrics
Theratechnologies Inc. Stock Analysis
Analyst Opinions
10 Analysts have issued a Theratechnologies Inc. forecast:
Analyst Opinions
10 Analysts have issued a Theratechnologies Inc. forecast:
Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.
| Head office | Canada |
| CEO | Mr. Levesque |
| Employees | 103 |
| Founded | 1993 |
| Website | www.theratech.com |


